C-reactive protein: Ligands, receptors and role in inflammation

Clinical Immunology

Volumn 117, Issue 2, 2005, Pages 104-111

  Marnell, Lorraine ^a,b   Mold, Carolyn ^a   Du Clos, Terry W ^a,c  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Biomedical Research Institute of New Mexico   (United States)

^c VA Medical Center   (United States)

Author keywords

Acute phase response; Animal models; C reactive protein; Innate immunity; Pentraxins; Systemic erythematosus

Indexed keywords

C REACTIVE PROTEIN; CLODRONIC ACID; FC RECEPTOR; LIGAND;

AUTOIMMUNITY; BACTERIAL INFECTION; CELL PROTECTION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 26044483536     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.08.004     Document Type: Short Survey

References (76)

1. W.S. Tillett, and T. Francis Jr. Serological reactions in pneumonia with a non-protein fraction of pneumococcus J. Exp. Med. 52 1930 561 571
2. M.H. Kaplan, and J.E. Volanakis Interactions of C-reactive protein with the complement system: I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin and sphingomyelin J. Immunol. 112 1974 2135 2147
3. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
4. J. Hurlimann, G.J. Thorbecke, and G.M. Hochwald The liver as the site of C-reactive protein formation J. Exp. Med. 123 1966 365 378
5. A. Mackiewicz, T. Speroff, M.K. Ganapathi, and I. Kushner Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines J. Immunol. 146 1991 3032 3037
6. A. Agrawal, H. Cha-Molstad, D. Samols, and I. Kushner Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3 Immunology 108 2003 539 547
7. D. Zhang, M. Sun, D. Samols, and I. Kushner STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6 J. Biol. Chem. 271 1996 9503 9509
8. A. Agrawal, D. Samols, and I. Kushner Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter Mol. Immunol. 40 2003 373 380
9. S.-P. Li, T.-Y. Liu, and N.D. Goldman cis-Acting elements responsible for interleukin-6 inducible C-reactive protein expression J. Biol. Chem. 265 1990 4136 4142
10. A.J. Szalai, J. Wu, E.M. Lange, M.A. McCrory, C.D. Langefeld, A. Williams, S.O. Zakharkin, V. George, D.B. Allison, G.S. Cooper, F. Xie, Z. Fan, J.C. Edberg, and R.P. Kimberly Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level J. Mol. Med. 83 2005 440 447
11. A.J. Szalai, M.A. McCrory, G.S. Cooper, J. Wu, and R.P. Kimberly Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene Genes Immun. 3 2002 14 19
12. A.I. Russell, D.S. Cunninghame Graham, C. Shepherd, C.A. Roberton, J. Whittaker, J. Meeks, R.J. Powell, D.A. Isenberg, M.J. Walport, and T.J. Vyse Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus Hum. Mol. Genet. 13 2004 137 147
13. A.J. Szalai, G.S. Alarcon, J. Calvo-Alen, S.M. Toloza, M.A. McCrory, J.C. Edberg, G. McGwin Jr., H.M. Bastian, B.J. Fessler, L.M. Vila, R.P. Kimberly, and J.D. Reveille Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA): XXX. Association between C-reactive protein (CRP) gene polymorphisms and vascular events Rheumatology (Oxford) 44 2005 864 868
14. H.J. Suk, P.M. Ridker, N.R. Cook, and R.Y. Zee Relation of polymorphism within the C-reactive protein gene and plasma CRP levels Atherosclerosis 178 2005 139 145
15. R.Y. Zee, and P.M. Ridker Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis Atherosclerosis 162 2002 217 219
16. C. Eklund, T. Lehtimaki, and M. Hurme Epistatic effect of C-reactive protein (CRP) single nucleotide polymorphism (SNP) +1059 and interleukin-1B SNP +3954 on CRP concentration in healthy male blood donors Int. J. Immunogenet. 32 2005 229 232
17. D. Brull, N. serrano, F. Zito, L. Jones, H. Montgomery, A. Rumley, P. Sharma, G. Love, M. World, S. Humphries, and A. Hingorani Human CRP gene polymorphism influences CRP levels. Implications for prediction and pathogenesis of coronary heart disease Arterioscler. Thromb. Vasc. Biol. 23 2003 2063 2069
18. D. Thompson, M.B. Pepys, and S.P. Wood The physiological structure of human C-reactive protein and its complex with phosphocholine Structure 7 1999 169 177
19. A.K. Shrive, G.M. Cheetham, D. Holden, D.A. Myles, W.G. Turnell, J.E. Volanakis, M.B. Pepys, A.C. Bloomer, and T.J. Greenhough Three dimensional structure of human C-reactive protein Nat. Struct. Biol. 3 1996 346 354
20. A. Agrawal, A.K. Shrive, T.J. Greenhough, and J.E. Volanakis Topology and structure of the C1q-binding site on C-reactive protein J. Immunol. 166 2001 3998 4004
21. L.L. Marnell, C. Mold, M.A. Volzer, R.W. Burlingame, and T.W. Du Clos C-reactive protein binds to FcγRI in transfected COS cells J. Immunol. 155 1995 2185 2193
22. R. Bang, L. Marnell, C. Mold, C. Chivington-Buck, K.T. Du Clos, and T.W. Du Clos Analysis of binding sites in human C-reactive protein for FcγRI, FcγRIIa and C1q by site-directed mutagenesis J. Biol. Chem. 280 2005 25095 25102
23. C. Gaboriaud, J. Juanhuix, A. Gruez, M. Lacroix, C. Darnault, D. Pignol, D. Verger, J.C. Fontecilla-Camps, and G.J. Arlaud The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties J. Biol. Chem. 278 2003 46974 46982
24. J.E. Volanakis, and M.H. Kaplan Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide Proc. Soc. Exp. Biol. Med. 136 1971 612 614
25. K.B. Bodman-Smith, M. Mbuchi, F.J. Culley, P.A. Bates, and J.G. Raynes C-reactive protein-mediated phagocytosis of Leishmania donovani promastigotes does not alter parasite survival or macrophage responses Parasite Immunol. 24 2002 447 454
26. J.N. Weiser, N. Pan, K.L. McGowan, D. Musher, A. Martin, and J. Richards Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein J. Exp. Med. 187 1998 631 640
27. P.M. Ng, Z. Jin, S.S. Tan, B. Ho, and J.L. Ding C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection J. Endotoxin Res. 10 2004 163 174
28. Y.P. Li, C. Mold, and T.W. Du Clos Sublytic complement attack exposes C-reactive protein binding sites on cell membranes J. Immunol. 152 1994 2995 3005
29. A.J. Narkates, and J.E. Volanakis C-reactive protein binding specificities: artificial and natural phospholipid bilayers Ann. N.Y. Acad. Sci. 389 1982 172 181
30. S.J. Kim, D. Gershov, X. Ma, N. Brot, and K.B. Elkon Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses Ann. N.Y. Acad. Sci. 987 2003 68 78
31. R. Hanayama, M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. Nagata Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice Science 304 2004 1147 1150
32. C. Mold, R. Baca, and T.W. Du Clos Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcγ receptors J. Autoimmun. 19 2002 147 154
33. D. Gershov, S. Kim, N. Brot, and K.B. Elkon C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity J. Exp. Med. 192 2000 1353 1363
34. J.D. Gitlin, J.I. Gitlin, and D. Gitlin Localization of C-reactive protein in synovium of patients with rheumatoid arthritis Arthritis Rheum. 20 1977 1491 1499
35. F.A. Robey, K.D. Jones, T. Tanaka, and T.Y. Liu Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein J. Biol. Chem. 259 1984 7311 7316
36. T.W. Du Clos, L.T. Zlock, and R.L. Rubin Analysis of the binding of C-reactive protein to histones and chromatin J. Immunol. 141 1988 4266 4270
37. F.A. Robey, K.D. Jones, and A.D. Steinberg C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro J. Exp. Med. 161 1985 1344 1356
38. G.S. Shephard, P.D. Van Helden, M. Strauss, L. Böhm, and F.C. De Beer Functional effects of CRP binding to nuclei Immunology 58 1986 489 494
39. T.W. Du Clos C-reactive protein reacts with the U1 small nuclear ribonucleoprotein J. Immunol. 143 1989 2553 2559
40. W.S. Jewell, L.L. Marnell, L.A. Rokeach, and T.W. Du Clos C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region Mol. Immunol. 30 1993 701 708
41. C. Mold, S. Nakayama, T.J. Holzer, H. Gewurz, and T.W. Du Clos C-reactive protein is protective against Streptococcus pneumoniae infection in mice J. Exp. Med. 154 1981 1703 1708
42. C. Mold, H. Gewurz, and T.W. Du Clos Regulation of complement activation by C-reactive protein Immunopharmacology 42 1999 23 30
43. G.J. Wolbink, M.V. Brouwer, S. Buysmann, I.J.M. ten Berge, and E.C. Hack CRP-mediated activation of complement in vivo J. Immunol. 157 1996 473 479
44. R. Nijmeijer, W.K. Lagrand, Y. Lubbers, C.A. Visser, C.J.L.M. Meijer, H.W.M. Niessen, and C.E. Hack C-reactive protein activates complement in infarcted human myocardium Am. J. Pathol. 163 2003 269 275
45. S. Bhakdi, M. Torzewski, K. Paprotka, S. Schmitt, H. Barsoom, P. Suriyaphol, S.R. Han, K.J. Lackner, and M. Husmann Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence Circulation 109 2004 1870 1876
46. T.W. Du Clos, and C. Mold C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity Immunol. Res. 30 2004 261 278
47. K.B. Bodman-Smith, A.J. Melendez, I. Campbell, P.T. Harrison, J.M. Allen, and J.G. Raynes C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcγRI) Immunology 107 2002 252 260
48. J.M. Tebo, and R.F. Mortensen Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937 J. Immunol. 144 1990 231 238
49. D. Bharadwaj, M.P. Stein, M. Volzer, C. Mold, and T.W. Du Clos The major receptor for C-reactive protein on leukocytes is Fcγ receptor II J. Exp. Med. 190 1999 585 590
50. M.P. Stein, J.C. Edberg, R.P. Kimberly, E.K. Mangan, D. Bharadwaj, C. Mold, and T.W. Du Clos C-reactive protein binding to FcγRIIa on human monocytes and neutrophils is allele-specific J. Clin. Invest. 105 2000 369 376
51. K.B. Bodman-Smith, R.E. Gregory, P.T. Harrison, and J.G. Raynes FcγRIIa expression with FcgammaRI results in C-reactive protein- and IgG-mediated phagocytosis J. Leukocyte Biol. 75 2004 1029 1035
52. D.E. Manolov, C. Rocker, V. Hombach, G.U. Nienhaus, and J. Torzewski Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcγRIIa Arterioscler. Thromb. Vasc. Biol. 24 2004 2372 2377
53. J.A. Swanson, and A.D. Hoppe The coordination of signaling during Fc receptor-mediated phagocytosis J. Leuk. Biol. 76 2004 1093 1103
54. M. Chi, S. Tridandapani, W. Zhong, K.M. Coggeshall, and R.F. Mortensen C-reactive protein induces signaling through FcγRIIa on HL-60 granulocytes J. Immunol. 168 2002 1413 1418
55. Q. Wang, X. Zhu, Q. Xu, X. Ding, Y.E. Chen, and Q. Song Effect of C-reactive protein on gene expression in vascular endothelial cells Am. J. Physiol.: Heart Circ. Physiol. 288 2005 1539 1545
56. S. Zhong, Q. Zen, J. Tebo, K. Schlottmann, M. Coggeshall, and R.F. Mortensen Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling J. Immunol. 161 1998 2533 2540
57. S. Devaraj, P.R. Kumaresan, and I. Jialal Effect of C-reactive protein on chemokine expression in human aortic endothelial cells J. Mol. Cell. Cardiol. 36 2004 405 410
58. T.N. Williams, C.X. Zhang, B.A. Game, L. He, and Y. Huang C-reactive protein stimulates MMP-1 expression in U937 histocytes through FcγRII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization Arterioscler. Thromb. Vasc. Biol. 24 2004 61 66
59. D. Bharadwaj, C. Mold, E. Markham, and T.W. Du Clos Serum amyloid P component binds to Fcγ receptors and opsonizes particles for phagocytosis J. Immunol. 166 2001 6735 6741
60. J. Yother, J.E. Volanakis, and D.E. Briles Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice J. Immunol. 128 1982 2374 2376
61. A.J. Szalai, D.E. Briles, and J.E. Volanakis Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice J. Immunol. 155 1995 2557 2563
62. J. Horowitz, J.E. Volanakis, and D.E. Briles Blood clearance of Streptococcus pneumoniae by C-reactive protein J. Immunol. 138 1987 2598 2603
63. C. Mold, B. Rodic-Polic, and T.W. Du Clos Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors J. Immunol. 168 2002 6375 6381
64. J.N. Weiser, and J. Pan Adaptation of Haemophilus influenzae to acquired and innate immunity based on phase variation of lipopolysaccharide Mol. Microbiol. 30 1998 767 775
65. A.J. Szalai, J.L. VanCott, J.R. McGhee, J.E. Volanakis, and W.H. Benjamin Jr. Human C-reactive protein is protective against fatal Salmonella enterica Serovar Typhimurium infection in transgenic mice Infect. Immun. 68 2000 5652 5656
66. C. Mold, H.D. Gresham, and T.W. Du Clos Serum amyloid P component and C-reactive protein mediate phagocytosis through murine FcγRs J. Immunol. 166 2001 1200 1205
67. M.B. Pepys Isolation of serum amyloid P-component (protein SAP) in the mouse Immunol. 37 1979 637 641
68. D. Xia, and D. Samols Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia Proc. Natl. Acad. Sci. U. S. A. 94 1997 2575 2580
69. C. Mold, W. Rodriguez, B. Rodic-Polic, and T.W. Du Clos C-reactive protein mediates protection from lipopolysaccharide through interactions with FcγR J. Immunol. 169 2002 7019 7025
70. H. Tilg, E. Vannier, G. Vachino, C.A. Dinarello, and J.W. Mier Antiinflammatory properties of hepatic acute phase proteins: preferential induction of Interleukin 1 (IL-1) receptor antagonist over IL-1b synthesis by human peripheral blood mononuclear cells J. Exp. Med. 178 1993 1629 1636
71. T.W. Du Clos, L.T. Zlock, P.S. Hicks, and C. Mold Decreased autoantibody levels and enhanced survival of (NZB × NZW) F1 mice treated with C-reactive protein Clin. Immunol. Immunopathol. 70 1994 22 27
72. W. Rodriguez, C. Mold, M. Kataranovski, J. Hutt, L.L. Marnell, and T.W. Du Clos Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein Arthritis Rheum. 52 2005 642 650
73. A.J. Szalai, C.T. Weaver, M.A. McCrory, F.W. van Ginkel, R.M. Reiman, J.F. Kearney, T.N. Marion, and J.E. Volanakis Delayed lupus onset in (NZB × NZW) F1 mice expressing a human C-reactive protein transgene Arthritis Rheum. 48 2003 1602 1611
74. A.N. Theofilopoulos, and F.J. Dixon Murine models of systemic lupus erythematosus Adv. Immunol. 37 1985 269 391
75. K.W. Moore, W. Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
76. H. Groux, and F. Cottrez The complex role of interleukin-10 in autoimmunity J. Autoimmun. 20 2003 281 285